NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/23/2024
Back to search
Official data from USPTO
PENNITRACIN MD 50-G
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PENNITRACIN MD 50-G
ST13
US500000076521046Class
5
Filing
76521046
Registration
2862287
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/23/2024
Trademark type
Word
Nice classes
5
Filing date
06/06/2003
Registration date
07/13/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
01/23/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2002-11-00
First use in commerce
2002-11-00
Drawing code
1
Owner type
03
Owner location
WILMINGTON, NC
Examiner
SOUDERS, MICHAEL
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PHARMGATE INC.
PHARMGATE LLC
Pennfield Oil Company
Representatives
Chad W. Swantz Suiter Swantz pc llo
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
MEDICATED ANIMAL FEED ADDITIVE
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
01/23/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
07/25/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/13/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/27/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/25/2015
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/12/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/12/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/12/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/12/2014
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
01/27/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
01/27/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/17/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/17/2010
E815
TEAS SECTION 8 & 15 RECEIVED
04/30/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
07/13/2004
PUBO
PUBLISHED FOR OPPOSITION
04/20/2004
NPUB
NOTICE OF PUBLICATION
03/31/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2003
PAPER RECEIVED
12/29/2003
CNRT
NON-FINAL ACTION MAILED
11/28/2003
DOCK
ASSIGNED TO EXAMINER
11/21/2003
Continuous trademark protection
Get notified about every new filing that threatens PENNITRACIN MD 50-G or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.